Related Experiment Videos

MR imaging of double-contrast enhanced porcine myocardial infarction. Correlation with microdialysis

S Nilsson1, M Wikström, A Ericsson

  • 1Department of Diagnostic Radiology, University Hospital, Uppsala, Sweden.

Insights

Gadolinium-DTPA-BMA (Gd-DTPA-BMA) and Dysprosium-DTPA-BMA (Dy-DTPA-BMA) contrast agents showed higher concentrations in infarcted myocardium. Dy-DTPA-BMA

Area of Science:

  • Cardiovascular Imaging
  • Biomedical Engineering
  • Radiology

Background:

  • Myocardial infarction (MI) diagnosis relies on imaging techniques.
  • Contrast agents enhance MR imaging visualization of tissue changes.
  • Investigating novel contrast agents for MI detection is crucial.

Purpose of the Study:

  • To evaluate if Dy-DTPA-BMA counteracts Gd-DTPA-BMA contrast enhancement in myocardial infarction.
  • To assess the distribution and behavior of Gd-DTPA-BMA and Dy-DTPA-BMA in infarcted myocardium.

Main Methods:

  • MR imaging was used in a porcine model of myocardial infarction.
  • Microdialysis probes were used to sample tissue fluid from ischemic and non-ischemic myocardium.
  • Inductively coupled plasma atomic emission spectrometry measured concentrations of Gd and Dy.

Main Results:

  • Both Gd-DTPA-BMA and Dy-DTPA-BMA concentrations were three times higher in infarcted myocardium compared to non-ischemic tissue.
  • Infarcted areas showed high signal intensity in ex vivo spin-echo MR sequences.
  • No significant susceptibility effects were detected for Dy-DTPA-BMA, suggesting compromised cell membrane integrity.

Conclusions:

  • Gd-DTPA-BMA and Dy-DTPA-BMA accumulate in infarcted myocardium.
  • The lack of Dy-DTPA-BMA susceptibility effects may indicate altered tissue integrity in myocardial infarction.
  • Further research is needed to understand the behavior of Dy-based contrast agents in compromised tissues.

Related Concept Videos